New study will focus on biomarkers in brain injury
Colleagues at Salford have begun recruiting to a new £3m NIHR-funded study evaluating biomarkers in mild traumatic brain injury. Professor Fiona...
-
More
-
MoreStudy shows safety of world’s first human graphene-based brain computer interface operation
Eight patients have been treated at Northern Care Alliance (NCA) in the world’s first-in-human study of graphene-brain interfaces to map...
-
MoreNational chordoma and chondrosarcoma skull base MDT is accepting referrals
The North West Neurosurgery Network, hosted by Northern Care Alliance NHS Foundation Trust, has launched its national multidisciplinary team meeting...
-
MoreStudy brings new hope for brain tumour diagnosis
New research indicates a simple blood test could detect the deadliest form of brain tumour. Researchers have developed an experimental...
-
MoreInflammation-related protein changes could help predict cognitive impairment after stroke – especially in smokers
Researchers have found that tracking changes in a protein linked to inflammation (interleukin-6) after a stroke could help identify people...
-
MoreColleagues unite to support brain tumour patients
Patients with low grade gliomas and their families heard how support is available throughout their brain tumour journey at a...
-
MorePioneering brain tumour study treats patients before surgery
A groundbreaking clinical trial could transform the treatment of glioblastoma, the most aggressive and deadly form of brain cancer. The...
-
MoreStudy will focus on brain tumour patients’ working lives
Five Northern Care Alliance NHS Foundation Trust (NCA) colleagues have been awarded MAHSC Neuroscience Clinical Fellowships to develop their research....
-
MoreLeading the way on new treatment for meningioma
Brain tumour experts at Salford Royal have treated the first patient in the UK with a new investigational drug that...
-
MoreWorld’s 1st human graphene-based brain computer interface procedure at Salford Royal
INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company pioneering graphene-based neural technologies, announced today the world’s first human procedure of...